{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:23:22Z","timestamp":1773221002802,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155702","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T13:42:54Z","timestamp":1463578974000},"page":"e0155702","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6639-5293","authenticated-orcid":true,"given":"Agricola","family":"Joachim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Geldmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Munseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Missanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Wahren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria R.","family":"Polonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Tatoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Maboko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hoelscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eligius F.","family":"Lyamuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnel","family":"Biberfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Kroidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Bakari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotta","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"D4","DOI":"10.1016\/j.vaccine.2015.03.059","article-title":"Prospects for a globally effective HIV-1 vaccine","volume":"33","author":"JL Excler","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"NM Flynn","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand","volume":"194","author":"P Pitisuttithum","year":"2006","journal-title":"J Infect Dis"},{"issue":"9653","key":"ref4","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"GE Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"ref6","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"SM Hammer","year":"2013","journal-title":"N Engl J Med"},{"issue":"23","key":"ref7","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"issue":"14","key":"ref8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"ref9","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","author":"M Bonsignori","year":"2012","journal-title":"J Virol"},{"issue":"22","key":"ref10","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"GD Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/592507","article-title":"Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara","volume":"198","author":"E Sandstrom","year":"2008","journal-title":"J Infect Dis"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1128\/CVI.00008-10","article-title":"Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes","volume":"17","author":"S Aboud","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"46","key":"ref13","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1016\/j.vaccine.2011.08.001","article-title":"Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania","volume":"29","author":"M Bakari","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/aid.2013.0149","article-title":"Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees","volume":"30","author":"C Nilsson","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"e0118486","DOI":"10.1371\/journal.pone.0118486","article-title":"Potent Functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults","volume":"10","author":"A Joachim","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"e0119629","DOI":"10.1371\/journal.pone.0119629","article-title":"Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: A phase IIa randomized clinical trial","volume":"10","author":"PJ Munseri","year":"2015","journal-title":"PLoS ONE"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"e25165","DOI":"10.1371\/journal.pone.0025165","article-title":"Phase I randomised clinical trial of an HIV-1(CN54), Clade C, trimeric envelope vaccine candidate delivered vaginally","volume":"6","author":"DJ Lewis","year":"2011","journal-title":"PLoS ONE"},{"issue":"S1","key":"ref18","first-page":"A9","article-title":"A phase I clinical trial of an HIV-1 (CN54), clade, trimeric envelope vaccine delivered by parenteral, nasal and vaginal routes of immunisation","volume":"29","author":"CA Cosgrove","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"e16333","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"RN Coler","year":"2011","journal-title":"PLoS ONE"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1128\/JVI.74.23.11367-11376.2000","article-title":"Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C\/B') recombinant strain in China","volume":"74","author":"L Su","year":"2000","journal-title":"J Virol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/08892220150217247","article-title":"Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents","volume":"17","author":"CM Rodenburg","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.vaccine.2010.12.034","article-title":"Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation","volume":"29","author":"MP Cranage","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1128\/JVI.00183-14","article-title":"Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes","volume":"88","author":"JF Mann","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"e88979","DOI":"10.1371\/journal.pone.0088979","article-title":"GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza","volume":"9","author":"CH Clegg","year":"2014","journal-title":"PLoS ONE"},{"key":"ref25","unstructured":"DAIDS. Division of AIDS table for grading the severity of adult and pediatric adverse events. 2004."},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-3156.2008.02047.x","article-title":"Laboratory reference values for healthy adults from southern Tanzania","volume":"13","author":"E Saathoff","year":"2008","journal-title":"Trop Med Int Health"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2010.08.028","article-title":"Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC","volume":"408","author":"TG Edmonds","year":"2010","journal-title":"Virology"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mehy.2009.07.014","article-title":"Revisiting the possibility of serious adverse events from the whole cell pertussis vaccine: were metabolically vulnerable children at risk?","volume":"74","author":"K Wilson","year":"2010","journal-title":"Med Hypotheses"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2005.12.004","article-title":"Acute metabolic crisis induced by vaccination in seven Chinese patients","volume":"35","author":"Y Yang","year":"2006","journal-title":"Pediatr Neurol"},{"issue":"228","key":"ref30","doi-asserted-by":"crossref","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"NL Yates","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:11:49Z","timestamp":1540026709000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155702"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155702","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}